Last reviewed · How we verify
Klaricid based triple therapy
Klaricid based triple therapy is a Small molecule drug developed by National Taiwan University Hospital. It is currently FDA-approved.
Klaricid, a small molecule, is used in triple therapy for the treatment of Helicobacter Pylori Infection. The triple therapy is one of the interventions studied for treating H. Pylori Infection, along with sequential and hybrid therapies, in real-world settings.
At a glance
| Generic name | Klaricid based triple therapy |
|---|---|
| Sponsor | National Taiwan University Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Impact of Helicobacter Pylori Eradication on the Vaginal Microecology Change
- Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection (PHASE2)
- Fecal Molecular Susceptibility-guided Hp First-line Therapy (PHASE4)
- Fecal Molecular Susceptibility-guided Hp Rescue Therapy (PHASE4)
- Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy, Vonoprazan-amoxicillin Dual Therapy and Proton Pump Inhibitor-based Standard Triple Therapy for Hp Eradication (NA)
- Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori Infection (PHASE3)
- Personalized vs Standard of Care Treatment for Helicobacter Pylori Eradication Among Veterans (PHASE3)
- Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Klaricid based triple therapy CI brief — competitive landscape report
- Klaricid based triple therapy updates RSS · CI watch RSS
- National Taiwan University Hospital portfolio CI
Frequently asked questions about Klaricid based triple therapy
What is Klaricid based triple therapy?
Who makes Klaricid based triple therapy?
What development phase is Klaricid based triple therapy in?
Related
- Manufacturer: National Taiwan University Hospital — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing